Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier

Balamurali K. Ambati, Emory Patterson, Pooja Jani, Crystal Jenkins, Eric Higgins, Nirbhai Singh, Tushar Suthar, Nehali Vira, Kimberly Smith, Ruth B Caldwell

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Purpose: Pathological neovascularisation within the normally avascular cornea is a serious event that can interfere with normal vision. Upregulation of vascular endothelial growth factor (VEGF) has been associated with neovascularisation in the eye, suggesting that maintaining low levels of VEGF is important for corneal avascularity and intact vision. This study aims to determine the expression profile and possible contribution of sVEGFR-1 to the corneal avascular barrier. Design: Experimental case series investigating VEGF and soluble fms-like tyrosine kinase (sFlt) levels in normal and neovascularised human corneas. Participants: Four normal human corneas, five human corneas with alkali burns, three human corneas with aniridia, one with ocular cicatricial pemphigoid and two with interstitial keratitis were examined. Methods: Western blot and immunonistochemical analyses were performed to determine sFlt and VEGF levels in normal and neovascularised human corneas. Immunoprecipitation was utilised to demonstrate sFlt-VEGF binding. Results: Normal human corneas strongly express sFlt in the corneal epithelium and weakly in the corneal stroma close to the limbus. VEGF is bound by sFlt in the normal human cornea. Neovascularised human corneas have greatly reduced expression of sFlt and significantly less VEGF bound by sFlt. Conclusions: sFlt is highly expressed in the human cornea and normally sequesters VEGF.

Original languageEnglish (US)
Pages (from-to)505-508
Number of pages4
JournalBritish Journal of Ophthalmology
Volume91
Issue number4
DOIs
StatePublished - Apr 1 2007

Fingerprint

Vascular Endothelial Growth Factor Receptor-1
Cornea
Vascular Endothelial Growth Factor A
Benign Mucous Membrane Pemphigoid
Aniridia
Pathologic Neovascularization
Corneal Stroma
Corneal Epithelium
Keratitis
Alkalies
Burns
Immunoprecipitation
Research Design
Up-Regulation
Western Blotting

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier. / Ambati, Balamurali K.; Patterson, Emory; Jani, Pooja; Jenkins, Crystal; Higgins, Eric; Singh, Nirbhai; Suthar, Tushar; Vira, Nehali; Smith, Kimberly; Caldwell, Ruth B.

In: British Journal of Ophthalmology, Vol. 91, No. 4, 01.04.2007, p. 505-508.

Research output: Contribution to journalArticle

Ambati, BK, Patterson, E, Jani, P, Jenkins, C, Higgins, E, Singh, N, Suthar, T, Vira, N, Smith, K & Caldwell, RB 2007, 'Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier', British Journal of Ophthalmology, vol. 91, no. 4, pp. 505-508. https://doi.org/10.1136/bjo.2006.107417
Ambati, Balamurali K. ; Patterson, Emory ; Jani, Pooja ; Jenkins, Crystal ; Higgins, Eric ; Singh, Nirbhai ; Suthar, Tushar ; Vira, Nehali ; Smith, Kimberly ; Caldwell, Ruth B. / Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier. In: British Journal of Ophthalmology. 2007 ; Vol. 91, No. 4. pp. 505-508.
@article{e87f41e48e7e4d8b991a3dfd026b2c25,
title = "Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier",
abstract = "Purpose: Pathological neovascularisation within the normally avascular cornea is a serious event that can interfere with normal vision. Upregulation of vascular endothelial growth factor (VEGF) has been associated with neovascularisation in the eye, suggesting that maintaining low levels of VEGF is important for corneal avascularity and intact vision. This study aims to determine the expression profile and possible contribution of sVEGFR-1 to the corneal avascular barrier. Design: Experimental case series investigating VEGF and soluble fms-like tyrosine kinase (sFlt) levels in normal and neovascularised human corneas. Participants: Four normal human corneas, five human corneas with alkali burns, three human corneas with aniridia, one with ocular cicatricial pemphigoid and two with interstitial keratitis were examined. Methods: Western blot and immunonistochemical analyses were performed to determine sFlt and VEGF levels in normal and neovascularised human corneas. Immunoprecipitation was utilised to demonstrate sFlt-VEGF binding. Results: Normal human corneas strongly express sFlt in the corneal epithelium and weakly in the corneal stroma close to the limbus. VEGF is bound by sFlt in the normal human cornea. Neovascularised human corneas have greatly reduced expression of sFlt and significantly less VEGF bound by sFlt. Conclusions: sFlt is highly expressed in the human cornea and normally sequesters VEGF.",
author = "Ambati, {Balamurali K.} and Emory Patterson and Pooja Jani and Crystal Jenkins and Eric Higgins and Nirbhai Singh and Tushar Suthar and Nehali Vira and Kimberly Smith and Caldwell, {Ruth B}",
year = "2007",
month = "4",
day = "1",
doi = "10.1136/bjo.2006.107417",
language = "English (US)",
volume = "91",
pages = "505--508",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",
number = "4",

}

TY - JOUR

T1 - Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier

AU - Ambati, Balamurali K.

AU - Patterson, Emory

AU - Jani, Pooja

AU - Jenkins, Crystal

AU - Higgins, Eric

AU - Singh, Nirbhai

AU - Suthar, Tushar

AU - Vira, Nehali

AU - Smith, Kimberly

AU - Caldwell, Ruth B

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Purpose: Pathological neovascularisation within the normally avascular cornea is a serious event that can interfere with normal vision. Upregulation of vascular endothelial growth factor (VEGF) has been associated with neovascularisation in the eye, suggesting that maintaining low levels of VEGF is important for corneal avascularity and intact vision. This study aims to determine the expression profile and possible contribution of sVEGFR-1 to the corneal avascular barrier. Design: Experimental case series investigating VEGF and soluble fms-like tyrosine kinase (sFlt) levels in normal and neovascularised human corneas. Participants: Four normal human corneas, five human corneas with alkali burns, three human corneas with aniridia, one with ocular cicatricial pemphigoid and two with interstitial keratitis were examined. Methods: Western blot and immunonistochemical analyses were performed to determine sFlt and VEGF levels in normal and neovascularised human corneas. Immunoprecipitation was utilised to demonstrate sFlt-VEGF binding. Results: Normal human corneas strongly express sFlt in the corneal epithelium and weakly in the corneal stroma close to the limbus. VEGF is bound by sFlt in the normal human cornea. Neovascularised human corneas have greatly reduced expression of sFlt and significantly less VEGF bound by sFlt. Conclusions: sFlt is highly expressed in the human cornea and normally sequesters VEGF.

AB - Purpose: Pathological neovascularisation within the normally avascular cornea is a serious event that can interfere with normal vision. Upregulation of vascular endothelial growth factor (VEGF) has been associated with neovascularisation in the eye, suggesting that maintaining low levels of VEGF is important for corneal avascularity and intact vision. This study aims to determine the expression profile and possible contribution of sVEGFR-1 to the corneal avascular barrier. Design: Experimental case series investigating VEGF and soluble fms-like tyrosine kinase (sFlt) levels in normal and neovascularised human corneas. Participants: Four normal human corneas, five human corneas with alkali burns, three human corneas with aniridia, one with ocular cicatricial pemphigoid and two with interstitial keratitis were examined. Methods: Western blot and immunonistochemical analyses were performed to determine sFlt and VEGF levels in normal and neovascularised human corneas. Immunoprecipitation was utilised to demonstrate sFlt-VEGF binding. Results: Normal human corneas strongly express sFlt in the corneal epithelium and weakly in the corneal stroma close to the limbus. VEGF is bound by sFlt in the normal human cornea. Neovascularised human corneas have greatly reduced expression of sFlt and significantly less VEGF bound by sFlt. Conclusions: sFlt is highly expressed in the human cornea and normally sequesters VEGF.

UR - http://www.scopus.com/inward/record.url?scp=34247220899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247220899&partnerID=8YFLogxK

U2 - 10.1136/bjo.2006.107417

DO - 10.1136/bjo.2006.107417

M3 - Article

C2 - 17151056

AN - SCOPUS:34247220899

VL - 91

SP - 505

EP - 508

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

IS - 4

ER -